Skip to main navigation Skip to search Skip to main content

A drug screen with approved compounds identifies amlexanox as a novel Wnt/β-catenin activator inducing lung epithelial organoid formation

  • Rita Costa
  • , Darcy E. Wagner
  • , Ali Doryab
  • , Martina M. De Santis
  • , Kenji Schorpp
  • , Ina Rothenaigner
  • , Mareike Lehmann
  • , Hoeke A. Baarsma
  • , Xueping Liu
  • , Otmar Schmid
  • , Monica Campillos
  • , Ali Önder Yildirim
  • , Kamyar Hadian
  • , Melanie Königshoff
  • Ludwig Maximilian University of Munich
  • Helmholtz Zentrum München - German Research Center for Environmental Health
  • Lund University
  • University of Groningen
  • University of Pittsburgh

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)4026-4041
Number of pages16
JournalBritish Journal of Pharmacology
Volume178
Issue number19
DOIs
StatePublished - Oct 2021
Externally publishedYes

ASJC Scopus Subject Areas

  • Pharmacology

Keywords

  • amlexanox
  • chronic obstructive pulmonary disease
  • emphysema
  • organoids
  • regenerative medicine
  • Wnt/β-catenin signalling pathway

Fingerprint

Dive into the research topics of 'A drug screen with approved compounds identifies amlexanox as a novel Wnt/β-catenin activator inducing lung epithelial organoid formation'. Together they form a unique fingerprint.

Cite this